Myelinating cells, oligodendrocytes in the CNS and Schwann cells in the peripheral nervous system produce an enormous amount of plasma membrane during the myelination process, making them particularly susceptible to disruptions of the secretory pathway. Endoplasmic reticulum stress, initiated by the accumulation of unfolded or misfolded proteins, activates the unfolded protein response, which adapts cells to the stress. If this adaptive response is insufficient, the unfolded protein response activates an apoptotic program to eliminate the affected cells. Recent observations suggest that endoplasmic reticulum stress in myelinating cells is important in the pathogenesis of various disorders of myelin, including Charcot-Marie-Tooth disease, Pelizaeus-Merzbacher disease and Vanishing White Matter Disease, as well as in the most common myelin disorder, multiple sclerosis. A better understanding of endoplasmic reticulum stress in myelinating cells has laid the groundwork for the design of new therapeutic strategies for promoting myelinating cell survival in these disorders.
Myelinating cells, oligodendrocytes in the CNS and Schwann cells in the peripheral nervous system (PNS) produce a vast amount of myelin as an extension of their plasma membrane ( Fig. 1) 1,2 . Myelin, which is a unique, lipid-rich multilamellar sheath that wraps around axons in the CNS and PNS, is not only essential for the fast conduction of the action potential along axons, but also for the maintenance of axonal integrity 3 . According to estimates from morphometric analyses, the mean surface area of myelin per mature myelinating cell is thousands of times greater than the surface area of a typical mammalian cell 1 . Thus, during the active phase of myelination, each myelinating cell must synthesize an enormous amount of myelin membrane proteins, cholesterol and membrane lipids through the secretory pathway 2 . Thus, it is not surprising that myelinating cells are highly sensitive to the disruption of the secretory pathway, particularly the homeostasis of the endoplasmic reticulum. Recent studies indicate that this increased susceptibility contributes to the pathogenesis of a number of myelin disorders [4] [5] [6] [7] [8] [9] [10] [11] .
The endoplasmic reticulum has three essential functions 12, 13 . Secretory proteins and proteins destined for the cell surface and other intracellular organelles are synthesized by ribosomes on the cytosolic surface of the endoplasmic reticulum and translocated into the endoplasmic reticulum lumen through a pore in the endoplasmic reticulum membrane. Inside the lumen, they are properly modified and folded. In addition, the biosynthesis of steroids, cholesterol and other lipids takes place on the cytoplasmic side of the endoplasmic reticulum membrane. Moreover, cellular calcium is mainly stored in the endoplasmic reticulum lumen. The concentration of calcium in the cytoplasm is primarily regulated by Ca 2+ transport into and out of the endoplasmic reticulum.
A number of cell stress conditions, such as a perturbed calcium homeostasis or redox status, elevated secretory protein synthesis rates, altered glycosylation levels and abnormally high cholesterol levels, can interfere with oxidative protein folding and can subsequently lead to the accumulation of unfolded or misfolded proteins in the endoplasmic reticulum lumen. This phenomenon has been referred to as endoplasmic reticulum stress [14] [15] [16] . As a consequence, the eukaryotic cell has evolved an adaptive coordinated response, the unfolded protein response (UPR; Fig. 2 and Table 1), to limit further accumulation of unfolded proteins in the endoplasmic reticulum. Three endoplasmic reticulum-resident transmembrane proteins involved in the UPR have been identified: pancreatic endoplasmic reticulum kinase (PERK), the kinase encoded by the inositol requiring 1 (IRE1, also known as ERN1) gene and activating transcription factor 6 (ATF6).
At the onset of endoplasmic reticulum stress, the most rapidly activated pathway is the PERK pathway, which couples protein folding in the endoplasmic reticulum with protein synthesis by phosphorylating the a subunit of eukaryotic translation initiation factor 2 (eIF2a) 17, 18 . The activation of the PERK-eIF2a pathway attenuates the initiation of translation in response to endoplasmic reticulum stress and enhances the stress-induced expression of numerous cytoprotective genes [19] [20] [21] . Activation of IRE1 initiates the splicing of X boxbinding protein (XBP-1) mRNA, producing an active transcription factor, spliced XBP-1 (sXBP-1) 22, 23 . In addition, ATF6 becomes an active transcription factor by transiting to the Golgi complex, where it is cleaved by the proteases S1P and S2P before translocating to the nucleus 24 . The activation of IRE1 signaling and the cleavage of ATF6 promote endoplasmic reticulum expansion and the expression of endoplasmic reticulum-localized chaperones, which facilitate protein folding in the endoplasmic reticulum 18, 25 . In multicellular organisms, if these adaptive responses are not sufficient to resolve the folding problems in the endoplasmic reticulum, the UPR will trigger an apoptotic program to eliminate the cells 26, 27 .
It has become increasingly clear that endoplasmic reticulum stress is an important feature of a number of human diseases, particularly those involving cells dedicated to the synthesis of secreted proteins, such as diabetes mellitus, liver diseases and inflammatory disorders [28] [29] [30] . In this review, we discuss the current understanding of the contribution of endoplasmic reticulum stress in myelinating cells to the pathogenesis of inherited myelin disorders, such as Charcot-Marie-Tooth disease, Pelizaeus-Merzbacher disease (PMD), Vanishing White Matter Disease, and multiple sclerosis, an autoimmune demyelination disorder of the CNS. We also examine the unique features of endoplasmic reticulum stress in myelinating cells and how the increased sensitivity of these cells to endoplasmic reticulum stress might provide selective therapeutic opportunities.
The secretory pathway in Charcot-Marie-Tooth disease Charcot-Marie-Tooth disease is one of the most common inherited neurological disorders in humans, affecting approximately 1 in 2,500 individuals. Charcot-Marie-Tooth disease is actually a group of disorders of the PNS that are caused by mutations in a number of distinct genes and can be categorized as primarily originating from either the myelinating cell (Charcot-Marie-Tooth 1) or the axons (CharcotMarie-Tooth 2) 31 . Mutations in genes encoding peripheral myelin proteins account for the majority of Charcot-Marie-Tooth 1 cases. Peripheral myelin protein zero (MPZ), a transmembrane glycoprotein, comprises greater than 50% of the total protein of peripheral myelin and a number of distinct point mutations in MPZ have been shown to be responsible for a dominant form of Charcot-Marie-Tooth 1B 32 . There is strong evidence that mutations in MPZ can lead to endoplasmic reticulum stress in myelinating Schwann cells 4, 5 . A previous study generated an authentic mouse model of Charcot-Marie-Tooth 1B that expresses a human disease-causing form of MPZ with a deletion of S63 (P0S63del) 4 . Studies with this mutant demonstrated that this mutation causes a perturbed alignment of hydrophobic residues in b strand C of MPZ that results in the retention of the mutant protein in the endoplasmic reticulum of Schwann cells and leads to increased levels of phosphorylated eIF2a (p-eIF2a), ATF4, ATF3 and CAATT enhancer binding protein homologous protein (CHOP) in the nerve, suggesting activation of the PERK pathway 5 . The spliced form of XBP-1 is also increased in the nerves of these animals, suggesting that the IRE1 pathway is activated. Moreover, cleavage of ATF6 was detected in the P0S63del nerve. Notably, the activation of the PERK, IRE1 and ATF6 pathways in P0S63del nerves is dose dependent, which strongly suggests that the retention of P0S63del in the endoplasmic reticulum results in the activation of the UPR in Schwann cells.
It has been shown that CHOP, a transcription factor that is downstream of the PERK-eIF2a pathway, is important in the apoptosis that results from endoplasmic reticulum stress and CHOP deletion protects various cell types from endoplasmic reticulum stress-induced apoptosis in cell culture and animal models 25, 33, 34 . A previous study showed that CHOP is undetectable in Schwann cells of normal nerves, but is present in the nuclei of P0S63del Schwann cells 5 . To determine the role of the CHOP pathway in the pathogenesis of the myelin abnormalities that occurs in the P0S63del nerve, P0S63del mice were crossed with Chop À/À (also known as Ddit3) mice 5 . In the absence of CHOP activity, the number of demyelinated fibers in P0S63del nerves is reduced and the behavioral and electrophysiological abnormalities are attenuated. Nevertheless, CHOP inactivation did not affect the number of apoptotic Schwann cells or the degree of hypomyelination in the P0S63del nerve 5 . The mechanism accounting for the detrimental effects of CHOP in Charcot-Marie-Tooth 1B remains to be determined.
Mutations in genes encoding peripheral myelin protein 22 (PMP22) are the most common cause for Charcot-Marie-Tooth 1 cases 32 . PMP22 is a highly hydrophobic transmembrane protein with four putative transmembrane domains. In humans, the molecular lesion that is responsible for the vast majority of Charcot-Marie-Tooth 1 cases is a duplication of the region of chromosome 17 that contains the PMP22 gene, resulting in increased expression of this membrane protein 35 . Similarly, enforced expression of wild-type PMP22 in Schwann cells of transgenic mice and rats results in a Charcot-Marie-Tooth-like disorder 36 . Cumulative evidence indicates that this is a gain-of-function disorder in which the increased expression of PMP22 has a deleterious effect on myelinating Schwann cells 37 . In addition, spontaneous dominant mouse mutations have been identified in the Pmp22 gene, Trembler and Trembler-J (Tr-J), which introduce nonconservative amino acid changes into hydrophobic domains of this protein. It has been demonstrated that misfolded Pmp22 Trembler and Pmp22 Tr-J associate with calnexin, an endoplasmic reticulum chaperone, and accumulate in the endoplasmic reticulum of Schwann cells 38, 39 . Moreover, a previous study has shown that treatment with the chemical compound curcumin, which is capable of promoting the transport of misfolded proteins from the endoplasmic reticulum to the plasma membrane, substantially attenuates Schwann cell apoptosis and improves the neuropathologic phenotype in Pmp22 Tr-J mice 40 . Taken together, these data indicate that the accumulation of mutant PMP22 in the endoplasmic reticulum causes the apoptosis of Schwann cells, resulting in myelin abnormalities. Nevertheless, this accumulation does not lead to increased expression of the endoplasmic reticulum stress markers binding immunoglobulin protein (BIP) or CHOP 39, 40 . These data suggest that the role of the UPR in the pathogenesis of Charcot-Marie-Tooth 1A mutations needs to be examined directly and in greater detail.
Severe endoplasmic reticulum stress in PMD PMD is an X chromosome-linked dysmyelinating disease of the CNS with a broad range of clinical severity that is caused by more than 60 known mutations, including missense and nonsense mutations, in the proteolipid protein 1 (PLP1) gene [41] [42] [43] . In addition, PLP1 gene duplications are responsible for approximately 50% of PMD cases. PLP and its alternatively spliced isoform, DM20, are believed to contain four membrane-spanning domains and together comprise approximately 50% of total CNS myelin protein. It is believed that mutant PLP has a dominant gain of toxic function, as PLP1 deletion does not affect oligodendrocyte development and myelination and Plp1 À/À mice have normal neurological function until late adulthood 41 . Moreover, the enforced expression of a wild-type Plp1 gene is not sufficient to rescue the Plp1 mutant phenotype [41] [42] [43] . A previous study demonstrated that PLP mutations cause oligodendrocyte death during the myelination process, at the developmental time point when oligodendrocytes are extending extensive processes, making contact with nearby axons and initiating the synthesis of the myelin proteins 44 . Several studies have shown that the mutant PLP proteins are not properly folded and accumulate in the endoplasmic reticulum 42, 45, 46 . COS-7 cells that are transfected with a number of distinct PLP mutants show accumulation of mutant proteins in the endoplasmic reticulum 7, 42 . In addition, immunohistochemical studies show perinuclear accumulation of mutant PLP proteins in the oligodendrocytes of PLP mutant mice 44, 47 . This was further supported by electron microscopy analyses, which provided direct evidence that mutant PLP proteins accumulate in the endoplasmic reticulum of oligodendrocytes, where they disturb the endoplasmic reticulum ultrastructure 42, 48 .
Strong evidence has also recently indicated that the accumulation of mutant PLP in the endoplasmic reticulum activates the UPR and leads to myelinating oligodendrocyte death 7, 49 . Mutant PLP that is expressed by transfected fibroblasts accumulates in the endoplasmic reticulum and substantially increases the expression of endoplasmic reticulum stress markers such as CHOP, BIP and ATF3, which are also upregulated in the oligodendrocytes of PLP mutant mice 7 . Notably, CHOP is localized to the nucleus in mutant oligodendrocytes, which is strongly indicative of the endoplasmic reticulum stress response 7 . Similarly, increased CHOP expression is seen in the oligodendrocyte nuclei of PMD patients 7 . Lastly, a previous study showed that oligodendrocytes from rats transgenically overexpressing PLP are characterized by swollen endoplasmic reticulum and increased expression of BIP, as well as disulfide isomerase, an endoplasmic reticulum enzyme involved in protein folding 6 .
To determine the involvement of endoplasmic reticulum stress in oligodendrocyte death in Plp1 mutant mice, one study used a genetic approach, crossing Chop À/À mice with Plp1 mutant mice 7 . The study found that the absence of CHOP notably exacerbated the clinical phenotype and increased oligodendrocyte apoptosis in Plp1 mutant mice. This protective effect of CHOP on oligodendrocytes during endoplasmic reticulum stress is in marked contrast with its proapoptotic effect on other cell types. The mechanisms accounting for the protective effect of CHOP on oligodendrocytes remain a mystery. The above-mentioned study showed that CHOP induction in Plp1 mutant mice does not enhance expression of proteins that normally act downstream of CHOP, such as DOC (downstream of CHOP) 1, 4, and 6 (ref. 7) . It is possible that CHOP has a distinct set of target genes depending on cell type, which is reflected in its cell-specific function.
The UPR and Vanishing White Matter Disease Vanishing White Matter Disease is an inherited autosomal-recessive hypomyelinating disorder. The discovery of missense mutations in the ubiquitously expressed genes encoding the five subunits of eIF2B in individuals with Vanishing White Matter Disease led to the identification of the genetic causes of Vanishing White Matter Disease 50, 51 . This is the first human disease that has been shown to be caused by a mutation in a gene encoding a protein synthesis factor. eIF2B functions in translation as a guanine nucleotide exchange factor, promoting the release of GDP from eIF2 and the formation of an active eIF2-GTP complex 52 . eIF2-GTP then binds aminoacylated initiator methionyl tRNA, forming a ternary complex that is essential for each translation initiation event. p-eIF2a reduces the activity of eIF2B, with the two proteins forming a nonproductive p-eIF2-eIF2B complex. eIF2B mutations may impair its response to p-eIF2a, particularly during cell stress 53 .
Although oligodendrocytes have been described as being abnormal and 'foamy' in appearance, no evidence has been presented that demonstrates a reduction of oligodendrocyte numbers in Vanishing White Matter Disease 54, 55 . Notably, a recent study presented evidence for the activation of the UPR in oligodendrocytes in individuals with Vanishing White Matter Disease, including increased levels of phosphorylated PERK, p-eIF2a, ATF4 and CHOP 8, 9 . Moreover, it has been shown that primary cultured fibroblasts from individuals with Vanishing White Matter Disease respond normally to endoplasmic reticulum stress by reduced global translation rates. Nevertheless, the induction of ATF4 is substantially enhanced in these cells compared with normal controls, despite there being equal levels of cell stress and p-eIF2a 56 . A recent study has shown that the enforced expression of a Vanishing White Matter Disease-causing eIF2B mutation in an oligodendroglial cell line leads to elevated basal levels of the endoplasmic reticulum stress markers ATF4, GADD34 and BIP and results in the hyperinduction of these markers in response to a pharmacological stress agent, indicating that the UPR adapts oligodendrocytes to Vanishing White Matter Disease-causing eIF2B mutations 57 .
The UPR and immune-mediated demyelinating disorders
Multiple sclerosis is the most common neurological disorder affecting young adults, with an estimated incidence of approximately 1 in 500 individuals. It is generally believed that multiple sclerosis and its animal Figure 2 The UPR pathway in eukaryotic cells. Endoplasmic reticulum (ER) stress triggers PERK dimerization and autophosphorylation. Activated PERK attenuates protein biosynthesis by phosphorylating eIF2a. Phosphorylated eIF2a also activates ATF4, which enhances the stress-induced expression of numerous cytoprotective genes. In addition, ATF4 increases the expression of CHOP, which induces GADD34 expression. GADD34 binds to PP1 and forms the GADD34-PP1 complex that specifically dephosphorylates eIF2a. Endoplasmic reticulum stress also triggers IRE1dimerization and autophosphorylation. Activation of IRE1 initiates the splicing of XBP-1 mRNA, producing an active transcription factor, sXBP-1. In addition, ATF6 becomes an active transcription factor by transiting to the Golgi complex, where it is cleaved by the proteases S1P and S2P. The activation of IRE1 signaling and the cleavage of ATF6 promote endoplasmic reticulum expansion and the expression of endoplasmic reticulum-localized chaperones. In multicellular organisms, if these adaptive responses are not sufficient to resolve the folding problems in the endoplasmic reticulum, the UPR will trigger an apoptotic program, such as activation of caspase 12 or CHOP, to eliminate the cells. model, experimental autoimmune encephalomyelitis (EAE), are Th1 T cell-mediated autoimmune diseases 58, 59 . The pathological hallmarks of multiple sclerosis and EAE include inflammation, demyelination, oligodendrocyte loss and axonal degeneration. Evidence is emerging that the UPR is involved in the disease pathogenesis of multiple sclerosis and EAE 10, 11, 60 . Gene chip analyses have shown upregulation of the endoplasmic reticulum stress-responsive genes ATF4 and HSP70 (also known as HSPA4) in multiple sclerosis demyelinated lesions 61, 62 . Another recent report has shown elevated expression of CHOP, BIP and XBP-1 in multiple cell types in multiple sclerosis demyelinated lesions, including oligodendrocytes, astrocytes, T cells and microglia 10 . Moreover, elevated levels of p-eIF2a have been observed in oligodendrocytes and infiltrating T cells in the CNS during the course of EAE 63, 64 .
Recent evidence has suggested that activation of the PERK-eIF2a pathway of the UPR in oligodendrocytes protects against EAE-induced oligodendrocyte death and demyelination 65 . Interferon-g (IFN-g), a T cell-derived pleiotropic cytokine, is believed to be important in the pathogenesis of multiple sclerosis and EAE 11, 66 . Delivery of IFN-g to the CNS before EAE onset ameliorated disease severity and prevented EAE-induced oligodendrocyte loss, demyelination and axonal damage 65 . Notably, the protective effects of this cytokine are accompanied with the activation of the PERK-eIF2a pathway in oligodendrocytes and are abrogated in PERK-deficient animals 65 . Although evidence has shown that IFN-g is capable of increasing eIF2a phosphorylation through activation of double-stranded RNAdependent protein kinase (PKR) 67 and the level of phosphorylated PKR is elevated in oligodendrocytes in the course of EAE 63 , we have previously demonstrated that IFN-g-induced eIF2a phosphorylation in oligodendrocytes is mediated by PERK and that the protective effect of IFN-g in EAE is dependent on PERK 65, 68 . Thus, these data provide strong evidence that the UPR that is induced by IFN-g is involved in the pathogenesis of immune-mediated demyelination diseases.
Remyelination is sufficiently robust to repair myelin damage and restore neurological function in some animal models of CNS demyelination. The remyelination process also occurs in the CNS of individuals with multiple sclerosis. Nevertheless, this remyelination is generally considered to be insufficient 69, 70 . Several reports have shown that IFN-g is an important cytokine that suppresses oligodendrocyte regeneration and inhibits remyelination in multiple sclerosis and EAE demyelinated lesions [71] [72] [73] . The detrimental effects of IFN-g on myelin repair are mediated by endoplasmic reticulum stress in the remyelinating oligodendrocytes 73 . Transgenic mice that ectopically express IFN-g in the CNS during development have a tremoring phenotype, oligodendrocyte loss and hypomyelination 68, 74, 75 . Activation of the PERK-eIF2a pathway is detected in the myelinating oligodendrocytes of these transgenic mice 68 . In addition, decreased activity of the PERK-eIF2a pathway via PERK inactivation exacerbates IFN-g-induced oligodendrocyte apoptosis and hypomyelination 68 , whereas increased activity of the PERK-eIF2a pathway via GADD34 inactivation has the opposite effect 76 . Moreover, the detrimental effects of IFN-g on remyelination in demyelinated lesions are associated with endoplasmic reticulum stress in remyelinating oligodendrocytes, as evidenced by the upregulation of BIP and CHOP and an elevated level of p-eIF2a 73 . Notably, PERK deficiency substantially exacerbates remyelinating oligodendrocyte apoptosis and remyelination failure induced by IFN-g in demyelinated lesions 73 .
It appears that endoplasmic reticulum stress has both beneficial and detrimental effects on oligodendrocyte survival in immune-mediated demyelination diseases. Endoplasmic reticulum stress induction in fully myelinated mature oligodendroytes promotes cell survival, but in actively myelinating/remyelinating oligodendrocytes leads to cell death. Although it is largely unknown how the UPR selectively initiates the apoptotic and adaptive pathways 77 , we speculate that the outcomes of endoplasmic reticulum stress in oligodendrocytes are probably determined by the developmental status of the cells 11, 60, 65 . During active myelination, the endoplasmic reticulum in oligodendrocytes is largely occupied with the production of enormous amounts of myelin proteins and lipids 1,2 . Therefore, its adaptive capacity may be limited at this stage. It is likely that the marked upregulation of protein synthesis initiated by the inflammatory response overloads the endoplasmic reticulum of myelinating cells, causing severe endoplasmic reticulum stress and cell death. In contrast, mature oligodendrocytes in adult mice produce just enough myelin proteins and lipids to maintain myelin structure homeostasis 78 . The endoplasmic reticulum in mature oligodendrocytes may have sufficient adaptive capacity to handle the increased protein load. In this situation, the resulting endoplasmic reticulum stress would be moderate and would not trigger the apoptotic program. Instead, the adaptive response activated by endoplasmic reticulum stress could act protectively against subsequent insults. 25, 33, 34 .
GADD34
A regulatory subunit of protein phosphatase 1 (PP1) that specifically dephosphorylates phosphorylated eIF2a. GADD34
blockage increases the levels of phosphorylated eIF2a in stressed cells and protects cells from the stresses 34, 90 .
ATF6
Activation of ATF6 promotes the expression of endoplasmic reticulum-localized chaperones 18, 25 .
IRE1
Activation of IRE1 initiates the splicing of X-box-binding protein (XBP-1) mRNA, producing an active transcription factor, spliced XBP-1 (refs. 22,23) . XBP-1
Spliced XBP-1 promotes endoplasmic reticulum expansion and the expression of endoplasmic reticulum-localized chaperones 18, 25 . Caspase-12
Activation of caspase-12, an endoplasmic reticulum-localized caspase, has been shown to be associated with cell apoptosis that is induced by endoplasmic reticulum stress 79, 80 .
The unique features of the UPR in myelinating cells As described in the discussion of myelin disorders above, there is evidence to suggest that myelinating cells respond to endoplasmic reticulum stress in a manner that is somewhat distinct from that observed in other cell types. For example, CHOP, which is a downstream effecter molecule of the PERK-eIF2a pathway, participates in the induction of the apoptotic response in most cell types, but does not appear to contribute to the UPR-induced apoptotic demise of myelinating cells 5, 7, 33 . In fact, activation of CHOP promotes oligodendrocyte survival during the endoplasmic reticulum stress that is induced by PLP mutations 7 . Moreover, it has been demonstrated that CHOP is important in demyelination in the P0 mutant nerve, but is not involved in Schwann cell apoptosis 5 . Caspase-12, an endoplasmic reticulum-localized caspase, has been shown to be important in apoptosis that is elicited by endoplasmic reticulum stress in neurodegenerative diseases 79, 80 . Although activation of caspase-12 is detected in the oligodendrocytes of PLP mutant mice, caspase-12 deletion does not substantially affect the clinical phenotype, oligodendrocyte apoptosis or myelin abnormalities in these mice 81 . In addition, the upregulation of ATF3 has been shown to occur in the oligodendrocytes of PLP mutant mice, but the deletion of ATF3 also fails to have an effect on oligodendrocyte apoptosis in these animals 82 . Taken together, these data indicate that the apoptotic process that is elicited by endoplasmic reticulum stress in myelinating cells is unique. A more detailed understanding of these unique features could be critical when considering potential therapeutic approaches for myelin disorders.
Perhaps, the considerable demand on the secretory pathway of actively myelinating cells has resulted in an alteration of the typical response to endoplasmic reticulum stress that is seen in other cell types. A more thorough assessment of the UPR in myelinating cells is essential for a better understanding of the response of these cells to endoplasmic reticulum stress. One difficulty in the study of the UPR in myelinating cells is that they appear to be most susceptible to secretory pathway perturbations while they are actively myelinating axons, diminishing the utility of examining their response to stresses in heterologous systems or in isolation. Therefore, the most informative studies have been carried out in vivo using mouse models. Nevertheless, recent advances in the development of in vitro myelination systems, in combination with siRNA technology, should allow for a more rapid characterization of the UPR in myelinating cells 83 .
Therapeutic potential and future directions Considerable progress has now been made toward a detailed understanding of the signaling pathways of the endoplasmic reticulum stress response. Recent studies indicate that manipulating these signaling pathways has the potential to be therapeutic. The chemical chaperones 4-phenylbutyric acid and taurine-conjugated ursodeoxycholic acid, which reduce the phosphorylation of PERK and IRE1 during endoplasmic reticulum stress, both substantially improve glucose tolerance and insulin sensitivity in insulin-resistant obese mice 84 . Another chemical chaperone, the resveratrol tetramer vaticanol B, which suppresses the expression of CHOP and BIP during endoplasmic reticulum stress, prevents endoplasmic reticulum stress-induced apoptosis 85 . In addition, treatment with salburinal, a small-molecule inhibitor of eIF2a dephosphorylation, results in sustained eIF2a phosphorylation and protects cells from endoplasmic reticulum stress and viral infection 86 .
Currently, there is no effective therapy for patients with disorders of myelinating cells. Therapeutic strategies that facilitate the transport of misfolded proteins out of the endoplasmic reticulum could be beneficial for these patients. It has been shown that treatment with curcumin promotes mutant PMP22 transport from the endoplasmic reticulum to the plasma membrane and attenuates Schwann cell apoptosis in Pmp22 Tr-J mice 40 . Moreover, our recent data demonstrate that treatment with salburinal promotes the survival of myelinating oligodendrocytes that have been exposed to IFN-g, implying that therapeutic strategies that enhance the PERK-eIF2a pathway could promote oligodendrocyte survival in immune-mediated demyelination diseases 76 . The manipulation of endoplasmic reticulum stress for therapeutic purposes, without causing severe side effects, is a formidable challenge. Nevertheless, just as actively myelinating cells show increased sensitivity to perturbations to the secretory pathway, these cells may also show selective sensitivity and benefit from modulators of the UPR.
Future studies will need to address the many open questions concerning the physiological importance of the various endoplasmic reticulum stress signaling pathways during the myelination process and the pathological importance of these pathways in myelin disorders. For example, considering the relative prevalence of the disorder, it is critical to know whether endoplasmic reticulum stress is an important participant in the pathogenesis of Charcot-Marie-Tooth 1 in patients that overexpress the membrane protein PMP22. Moreover, the unique aspects of the UPR in myelinating cells need to be better understood. The knowledge gained from such studies will provide a strong foundation for the design of therapeutic strategies for these diseases. In addition, insights gained from these efforts might prove to be applicable to neurodegenerative disorders that show the selective vulnerability of specific neuronal subtypes. Neuronal populations with excessive secretory requirements might have increased sensitivity to factors, genetic and environmental, that disrupt endoplasmic reticulum function 87 . Future investigations into this possibility might be enlightening.
